We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+23.56%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$135M
AUM Growth
+$62.2M
(+86%)
Cap. Flow
+$48.4M
Cap. Flow
% of AUM
35.91%
Top 10 Holdings %
Top 10 Hldgs %
44.79%
Holding
162
New
9
Increased
113
Reduced
25
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$4.79M |
| 2 |
EEP
Enbridge Energy Partners
EEP
|
+$3.1M |
| 3 |
Plains All American Pipeline
PAA
|
+$2.86M |
| 4 |
WPZ
Williams Partners L.P.
WPZ
|
+$2.84M |
| 5 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$2.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Targa Resources
TRGP
|
+$572K |
| 2 |
XNPT
XENOPORT, INC.
XNPT
|
+$458K |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
+$291K |
| 4 |
Theravance Biopharma
TBPH
|
+$289K |
| 5 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
+$275K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 64.17% |
| 2 | Healthcare | 25.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
126
DELISTED
Adaptimmune Therapeutics
ADAP
| $220K | 0.16% |
26,974
-1,208
| -4% | -$11.4K |
|
|
CEMP
127
DELISTED
Cempra, Inc.
CEMP
| $219K | 0.16% |
13,284
+5,226
| +65% | +$92.2K |
|
|
IMGN
128
DELISTED
Immunogen Inc
IMGN
| $218K | 0.16% |
70,796
+51,539
| +268% | +$323K |
|
129
TG Therapeutics
TGTX
$8.5B
| $214K | 0.16% |
35,297
+11,311
| +47% | +$91.9K |
|
|
ALDR
130
DELISTED
Alder Biopharmaceuticals
ALDR
| $214K | 0.16% |
8,582
+1,309
| +18% | +$35.4K |
|
131
Agios Pharmaceuticals
AGIO
$2.16B
| $212K | 0.16% |
5,068
+114
| +2% | +$5.63K |
|
|
AIMT
132
DELISTED
Aimmune Therapeutics
AIMT
| $211K | 0.16% |
19,501
+5,835
| +43% | +$79.3K |
|
|
ACHN
133
DELISTED
Achillion Pharmaceuticals
ACHN
| $210K | 0.16% |
26,915
+1,204
| +5% | +$10.3K |
|
134
Karyopharm Therapeutics
KPTI
$161M
| $205K | 0.15% |
2,041
+846
| +71% | +$110K |
|
135
Ultragenyx Pharmaceutical
RARE
$2.66B
| $198K | 0.15% |
4,050
+1,646
| +68% | +$106K |
|
136
uniQure
QURE
$2.71B
| $195K | 0.14% |
26,511
+12,329
| +87% | +$147K |
|
|
GBT
137
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $194K | 0.14% |
11,710
+4,128
| +54% | +$83.3K |
|
138
Prothena Corp
PRTA
$447M
| $193K | 0.14% |
5,509
+1,859
| +51% | +$81K |
|
|
IMMU
139
DELISTED
Immunomedics Inc
IMMU
| $188K | 0.14% |
81,010
-6,052
| -7% | -$20.2K |
|
|
ESPR
140
DELISTED
Esperion Therapeutics
ESPR
| $154K | 0.11% |
15,540
+4,529
| +41% | +$75K |
|
|
NS
141
DELISTED
NuStar Energy L.P.
NS
| $152K | 0.11% |
3,057
+1,469
| +93% | +$70.3K |
|
|
RGLS
142
DELISTED
Regulus Therapeutics
RGLS
| $134K | 0.1% |
386
+132
| +52% | +$94.5K |
|
|
SEP
143
DELISTED
Spectra Engy Parters Lp
SEP
| $132K | 0.1% |
2,788
+1,339
| +92% | +$62.8K |
|
144
Oneok
OKE
$58.7B
| $113K | 0.08% |
+2,378
| New | +$94.3K |
|
145
United States Oil Fund
USO
$2.5B
| $16K | 0.01% |
178
-2,322
| -93% | -$208K |
|
146
CALL
State Street
STT
$50.6B
| $9K | 0.01% |
+150
| New | +$8.96K |
|
|
147
PUT
State Street
STT
$50.6B
| $2K | ﹤0.01% |
+300
| New | +$17.9K |
|
148
Arbutus Biopharma
ABUS
$883M
| – | – |
-54,471
| Closed | -$225K |
|
149
Ardelyx
ARDX
$1.27B
| – | – |
-12,922
| Closed | -$100K |
|
|
TVRD
150
Tvardi Therapeutics
TVRD
$24M
| – | – |
-452
| Closed | -$101K |
|
Similar funds
NCM
OC
SSA
LIWM
VFG
IAM
1M
GC
Virtus ETF Advisers's Q2 2016 Portfolio in Review
As of Q2 2016, Virtus ETF Advisers held 162 positions worth $135M, up 86% from $72.6M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Virtus ETF Advisers deployed $48.4M of net new capital in Q2 2016, opening 9 new positions and adding to 113 existing holdings. Its largest new stake was Cheniere Energy: 11,685 shares worth $350K.
By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 49% a quarter earlier, followed by Healthcare.
On the sell side, the largest reduction was Targa Resources, an estimated $572K trimmed.
- Virtus ETF Advisers's largest Q2 2016 buy was Cheniere Energy: 11,685 shares worth $350K.
- Virtus ETF Advisers added most to Energy Transfer Partners L.p. in Q2 2016, an estimated $4.79M increase.
- Virtus ETF Advisers's biggest Q2 2016 reduction was Targa Resources, cutting an estimated $572K.
- Virtus ETF Advisers fully exited XENOPORT, INC. in Q2 2016, selling an estimated $458K.
- Virtus ETF Advisers's ten largest holdings make up 45% of its $135M portfolio in Q2 2016.
- Virtus ETF Advisers opened 9 new positions and closed 15 in Q2 2016.
- Virtus ETF Advisers's portfolio value rose 86% quarter-over-quarter to $135M.
Based on Virtus ETF Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.